124 related articles for article (PubMed ID: 34914287)
21. [Genes and signaling pathways related to the biochemical recurrence of prostate cancer: An analysis based on the GEO database].
Chen ZJ; Guan H; Wang S; Xu B; Chen M
Zhonghua Nan Ke Xue; 2021 Jan; 27(1):17-25. PubMed ID: 34914276
[TBL] [Abstract][Full Text] [Related]
22. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
Vastrad B; Vastrad C; Tengli A; Iliger S
Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
[TBL] [Abstract][Full Text] [Related]
23. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
Xue H; Sun Z; Wu W; Du D; Liao S
Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084
[TBL] [Abstract][Full Text] [Related]
24. Identification of aberrantly methylated differentially expressed genes in prostate carcinoma using integrated bioinformatics.
Wu K; Yin X; Jin Y; Liu F; Gao J
Cancer Cell Int; 2019; 19():51. PubMed ID: 30872976
[TBL] [Abstract][Full Text] [Related]
25. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
Li G; Cai L; Zhou L
Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
[TBL] [Abstract][Full Text] [Related]
26. Identification of candidate hub genes correlated with the pathogenesis, diagnosis, and prognosis of prostate cancer by integrated bioinformatics analysis.
Wei T; Liang Y; Anderson C; Zhang M; Zhu N; Xie J
Transl Cancer Res; 2022 Oct; 11(10):3548-3571. PubMed ID: 36388030
[TBL] [Abstract][Full Text] [Related]
27. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis.
Xing X; Xia Q; Gong B; Shen Z; Zhang Y
Front Genet; 2022; 13():855557. PubMed ID: 35368701
[No Abstract] [Full Text] [Related]
28. Identification of potential biomarkers of gout through competitive endogenous RNA network analysis.
Li Y; Huang C; Yang Z; Wang L; Luo D; Qi L; Li Z; Huang Y
Eur J Pharm Sci; 2022 Jun; 173():106180. PubMed ID: 35378210
[TBL] [Abstract][Full Text] [Related]
29. Identification of Hub Genes in Duchenne Muscular Dystrophy: Evidence from Bioinformatic Analysis.
Zhang R; Lv L; Ban W; Dang X; Zhang C
J Comput Biol; 2020 Jan; 27(1):1-8. PubMed ID: 31390219
[TBL] [Abstract][Full Text] [Related]
30. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
31. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.
Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
[TBL] [Abstract][Full Text] [Related]
33. Identification of hub genes predicting the development of prostate cancer from benign prostate hyperplasia and analyzing their clinical value in prostate cancer by bioinformatic analysis.
Chen X; Ma J; Xu C; Wang L; Yao Y; Wang X; Zi T; Bian C; Wu D; Wu G
Discov Oncol; 2022 Jun; 13(1):54. PubMed ID: 35768705
[TBL] [Abstract][Full Text] [Related]
34. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
Baruah MM; Sharma N
Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
[TBL] [Abstract][Full Text] [Related]
35. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
37. Study on potential differentially expressed genes in stroke by bioinformatics analysis.
Yang X; Wang P; Yan S; Wang G
Neurol Sci; 2022 Feb; 43(2):1155-1166. PubMed ID: 34313877
[TBL] [Abstract][Full Text] [Related]
38. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
[TBL] [Abstract][Full Text] [Related]
39. Identification of hub genes and pathways in bladder cancer using bioinformatics analysis.
Li D; Zhen F; Le J; Chen G; Zhu J
Am J Clin Exp Urol; 2022; 10(1):13-24. PubMed ID: 35291419
[TBL] [Abstract][Full Text] [Related]
40. Identification of Hub Genes in Type 2 Diabetes Mellitus Using Bioinformatics Analysis.
Lin Y; Li J; Wu D; Wang F; Fang Z; Shen G
Diabetes Metab Syndr Obes; 2020; 13():1793-1801. PubMed ID: 32547141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
